Ainhoa Gomez Lumbreras, MD, PhD
Medical Doctor, Family Physician and Clinical Pharmacology specialist. After 10 years of clinical practice in primary care and emergency room hospital settings in Spain I obtained my PhD in pharmacology in Universitat Autonoma de Barcelona by conducting a study of antidepressants use and the risk of hip fracture.
Pharmacoepidemiology; Drug-drug interactions; Adverse outcomes; Ethics of the research;
Sabrina Ilham, PharmD
I am a PharmD graduate from the University of Connecticut. I gravitated towards clinical research as a student and during my clinical training. I am currently working as a postdoctoral research fellow where I supplement as well as apply my clinical knowledge in designing various types of studies, e.g., real-world evidence synthesis, cost effectiveness analysis.
I am interested in learning about different research methodologies, e.g., real-world observational study, systematic review, and meta-analysis, pharmacoeconomic analysis.
- Aditi Kharat, Rupesh Panchal, Sabrina Ilham, Madeline Brendle, Trang Au, Ronda Copher, David Huggar, Ali McBride, Connor Willis, and Diana I. Brixner. Challenges and opportunities of alternative payment models for physicians/quality officers in community/academic oncology practice sites via a national prospective survey. Journal of Clinical Oncology 2021 39:28_suppl, 46-46
- Miao, B., Chalupadi, B., Clark, B., Descoteaux, A., Huang, D., Ilham, S., Ly, B., Spyropoulos, A. C., & Coleman, C. I. (2019). Proportion of US Hospitalized Medically Ill Patients Who May Qualify for Extended Thromboprophylaxis. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 25, 1076029619850897 https://doi.org/10.1177/1076029619850897
- Martinez, B.K., Yik, B., Tran, R., Ilham, S., Coleman, C.I., Jennings, D.L. and Baker, W.L. (2018), Meta-Analysis of Time in Therapeutic Range in Continuous-Flow Left Ventricular Assist Device Patients Receiving Warfarin. Artificial Organs, 42: 700-704. https://doi.org/10.1111/aor.13116
Niying Li, PhD
Niying Li is currently a post-doctoral fellow in the Pharmacotherapy Outcomes Research Center of University of Utah College of Pharmacy. She received her PhD in Health Services Research in Pharmacy from the University of Wisconsin-Madison, MSc in Health Policy from the University of Edinburgh in the United Kingdom, and a BS in Pharmacy from Guangdong Pharmaceutical University in China. She conducts empirical research in health policy using secondary data.
Her research interests include quality of care, caregiving, and global health.
Rupesh Panchal, PharmD
Rupesh Panchal is a second-year postdoctoral fellow with the University of Utah Health Plans and Pharmacotherapy Outcomes Research Center. Rupesh received his Doctorate of Pharmacy (PharmD) from the University of Texas at Austin. Prior to entering the fellowship, Rupesh’s past experiences include involvement in clinical research, managed care, and hospital pharmacy. Rupesh was able to work on various projects which provided him exposure in utilizing retrospective claims data, the electronic health record, and summarizing clinical evidence for formulary management decisions.
Rupesh’s interests include assessing the impact of health policy and interventions on outcomes and translating real world evidence to payers.
Weston Schmutz, PharmD
Weston graduated with his PharmD from the University of Utah College of Pharmacy in 2021. He currently is a first-year fellow at the Pharmacotherapy Outcomes Research Center and currently assists with writing proposals and study conduction. Weston enjoys the vast number of projects PORC has been able to provide him with dealing in a variety of disease states, education, and new study models.
Racial disparities in cancer care and how real-world evidence can be better applied.
Chia Jie Tan, PhD
Chia Jie graduated from the University of South Australia with a Bachelor of Pharmacy (Hons) in 2010 and practised as an oncology pharmacist for several years in Malaysia, obtaining BPS board certification in oncology in 2016. Following that, he pursued his PhD at the National University of Singapore, examining health outcomes among cancer survivors. Chia Jie has also been involved in both observational studies and interventional trials evaluating supportive care measures to ameliorate cancer- and treatment-related complications. As part of his postdoctoral fellowship at the University of Utah, he is aiming to acquire more skills and experience in health economics and outcomes research.
Health economics, specifically health technology assessment and patient preference studies.
Malinda S. Tan, PharmD
Dr. Tan obtained a PharmD degree from the University of Utah College of Pharmacy. Currently, she is a postdoctoral fellow at the University of Utah, Pharmacotherapy Outcomes Research Center. She has experience in outcomes research using electronic health record databases, real-world patient-reported outcomes, and economic modeling. She also has experience research and dissemination of evidence regarding drug-drug interaction, and decision support tools to improve patient safety.
Her current interests include outcomes research across a broad range of disease and dissemination of decision supports related to medication safety.
Sajesh K Veettil, PhD
Sajesh Veettil is a post-doctoral research fellow in the Pharmacotherapy Outcomes Research Center of the University of Utah College of Pharmacy. He obtained his Ph.D. in Medical and Health Sciences from International Medical University in Malaysia (2019), with a focus on evidence synthesis and economic evaluation (2019). He earned a master's degree in pharmacy practice (2008) and a bachelor's degree in pharmacy (2005). He was a pharmacy academician for around 13 years at various Universities teaching both undergraduate and post-graduate students (2008-2019). He sees himself as a researcher who focuses on evidence synthesis and economic analyses. Currently he has more than 50 peer-reviewed articles to his credit.
Evidence synthesis and economic analyses.